Skip to main content
. 2019 Nov 6;24(1):34–39. doi: 10.1111/jcmm.14770

Figure 3.

Figure 3

The potential functions of Card9 in IBD. A, CARD9 deficiency impaired immune responses; B, CARD9 controlled gut microbiota; C, CARD9 altered gut microbiota metabolism; D, the positive therapeutic effect of CARD9‐targeting small‐molecule inhibitor